Cannabis and stimulant disorders and readmission 2 years after first-episode psychosis

27Citations
Citations of this article
77Readers
Mendeley users who have this article in their library.

Abstract

Background: Few studies have examined the impact of stimulant use on outcome in early psychosis. Ceasing substance use may lead to positive outcomes in psychosis. Aims: To examine whether baseline cannabis or stimulant disorders and ongoing drug use predict readmission within 2 years of a first psychosis admission. Method: Predictors of readmission were examined with Cox regression in 7269 people aged 15-29 years with a first psychosis admission. Results: Baseline cannabis and stimulant disorders did not predict readmission. A stimulant disorder diagnosis prior to index psychosis admission predicted readmission, but a prior cannabis disorder diagnosis did not. Ongoing problem drug use predicted readmission. The lowest rate of readmission occurred in people whose baseline drug problems were discontinued. Conclusions: Prior admissions with stimulant disorder may be a negative prognostic sign in first-episode psychosis. Drug use diagnoses at baseline may be a good prognostic sign if they are identified and controlled. Declaration of interest: None.

Cite

CITATION STYLE

APA

Sara, G. E., Burgess, P. M., Malhi, G. S., Whiteford, H. A., & Hall, W. C. (2014). Cannabis and stimulant disorders and readmission 2 years after first-episode psychosis. British Journal of Psychiatry, 204(6), 448–453. https://doi.org/10.1192/bjp.bp.113.135145

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free